CABA

Cabaletta Bio's stock has experienced notable movements in the past six months. The share price was $4.00 as of May 7, 2026, a substantial increase from $1.21 on May 8, 2025. Shares jumped 30% in May 2026 after the company reported promising early data from patients with pemphigus vulgaris treated with rese-cel. Cabaletta Bio launched an underwritten public offering of 51,725,000 shares at $2.90 per share, aiming to raise approximately $150 million. Insider buying activity has also been observed.